Cui C, Niu X, Li H, Zhang R, Geng L, Lin W
Clin Drug Investig. 2025; .
PMID: 40074970
DOI: 10.1007/s40261-025-01428-9.
Yazbeck H, Youssef J, Nasreddine W, El Kurdi A, Zgheib N, Beydoun A
Front Pharmacol. 2024; 15:1483723.
PMID: 39539630
PMC: 11558073.
DOI: 10.3389/fphar.2024.1483723.
Zhao Y, Liu H, Xiao C, Hou J, Zhang B, Li J
Front Pharmacol. 2024; 14:1323755.
PMID: 38239188
PMC: 10794455.
DOI: 10.3389/fphar.2023.1323755.
Roberts B, Cooper Z, Lu S, Stanley S, Majda B, Collins K
Front Pharmacol. 2023; 14:1267294.
PMID: 37795032
PMC: 10545970.
DOI: 10.3389/fphar.2023.1267294.
Park J, Seo K, Choi S, Yoon M, Hwang G, Tahk S
Medicine (Baltimore). 2023; 102(37):e35187.
PMID: 37713877
PMC: 10508429.
DOI: 10.1097/MD.0000000000035187.
Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling.
Jacobs T, de Hoop-Sommen M, Nieuwenstein T, Van Der Heijden J, de Wildt S, Burger D
Pharmaceutics. 2023; 15(5).
PMID: 37242665
PMC: 10221211.
DOI: 10.3390/pharmaceutics15051424.
Factors Associated With Enrollment into Inpatient Coronavirus Disease 2019 Randomized Controlled Trials: A Cross-sectional Analysis.
Kaczynski M, Benitez G, Mylona E, Tran Q, Atalla E, Tsikala-Vafea M
Open Forum Infect Dis. 2023; 10(5):ofad197.
PMID: 37180601
PMC: 10173548.
DOI: 10.1093/ofid/ofad197.
Clinical outcomes of chemotherapy in cancer patients with different ethnicities.
Pathak S, Zajac K, Annaji M, Govindarajulu M, Nadar R, Bowen D
Cancer Rep (Hoboken). 2023; 6 Suppl 1:e1830.
PMID: 37150853
PMC: 10440845.
DOI: 10.1002/cnr2.1830.
Pharmacokinetic characteristics of golidocitinib, a highly selective JAK1 inhibitor, in healthy adult participants.
Chen K, Guan X, Yang Z, Zhou Y, Liu Z, Deng X
Front Immunol. 2023; 14:1127935.
PMID: 37077916
PMC: 10108266.
DOI: 10.3389/fimmu.2023.1127935.
Epidemiology of adverse events attributed to airway management in paediatric anaesthesia: protocol for the prospective, multicentre, registry-based, cross-sectional Japan Pediatric Difficult Airway in Anesthesia study (J-PEDIA).
Kojima T, Yamauchi Y, Watanabe F, Ichiyanagi S, Kobayashi Y, Kaiho Y
BMJ Open. 2023; 13(4):e067554.
PMID: 37068905
PMC: 10111891.
DOI: 10.1136/bmjopen-2022-067554.
Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.
Cacabelos R, Naidoo V, Martinez-Iglesias O, Corzo L, Cacabelos N, Pego R
Methods Mol Biol. 2022; 2547:275-387.
PMID: 36068470
DOI: 10.1007/978-1-0716-2573-6_13.
Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers.
Brazelton A, Yande S, Pope R, Johnson M, Musher B, Trivedi M
Ann Gastroenterol. 2022; 35(2):182-186.
PMID: 35479584
PMC: 8922257.
DOI: 10.20524/aog.2022.0688.
Long-Term Effect of β-Blocker Use on Clinical Outcomes in Postmyocardial Infarction Patients: A Systematic Review and Meta-Analysis.
Liang C, Zhang C, Gan S, Chen X, Tan Z
Front Cardiovasc Med. 2022; 9:779462.
PMID: 35463744
PMC: 9024047.
DOI: 10.3389/fcvm.2022.779462.
Pharmacogenomic landscape of Indian population using whole genomes.
Sahana S, Bhoyar R, Sivadas A, Jain A, Imran M, Rophina M
Clin Transl Sci. 2022; 15(4):866-877.
PMID: 35338580
PMC: 9010271.
DOI: 10.1111/cts.13153.
A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects.
Trivedi A, Mather O, Vega S, Hutton S, Hellawell J, Lee E
Drugs R D. 2022; 22(2):141-146.
PMID: 35279815
PMC: 9167390.
DOI: 10.1007/s40268-022-00386-3.
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.
Kim B, Yoon D, Lee S, Jang I, Yu K, Cho J
Transl Clin Pharmacol. 2021; 29(3):135-149.
PMID: 34621706
PMC: 8492395.
DOI: 10.12793/tcp.2021.29.e14.
Rare variants discovery by extensive whole-genome sequencing of the Han Chinese population in Taiwan: Applications to cardiovascular medicine.
Juang J, Lu T, Su M, Lin C, Yang J, Chu H
J Adv Res. 2021; 30:147-158.
PMID: 34026292
PMC: 8132201.
DOI: 10.1016/j.jare.2020.12.003.
Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease.
He W, Shu X, Zhu E, Deng B, Lin Y, Wu X
BMC Cardiovasc Disord. 2021; 21(1):75.
PMID: 33546595
PMC: 7863361.
DOI: 10.1186/s12872-021-01884-z.
Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.
Wang T, Zhou Y, Cao G
Eur J Clin Pharmacol. 2021; 77(8):1095-1111.
PMID: 33515076
DOI: 10.1007/s00228-021-03088-y.
Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention.
Namazi S, Sahebi E, Azarpira N, Rostami-Yalmeh J, Kojuri J, Khalili A
Iran J Pharm Res. 2020; 19(2):307-316.
PMID: 33224237
PMC: 7667545.
DOI: 10.22037/ijpr.2020.1101083.